XYLYX BIO, INC.

BROOKLYN, NY

OncologyPhase II

What changed

Phase II trial registered: Duloxetine and aeRobic Exercise to Improve Function in VEterans With Knee Osteoarthritis (DRIVE)

4w agoTrial registeredJun 16, 2026Source filing (opens the source filing in a new tab)

Momentum

100no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Trial
PHASE2 registered
Mar 1, 2027
Knee Osteoarthritis, Pain, Depression · NOT_YET_RECRUITING · sponsor: VA Office of Research and Development · Duloxetine and aeRobic Exercise to Improve Function in VEterans With Knee Osteoarthritis (DRIVE)
ClinicalTrials.gov · NCT07649291 (opens the source filing in a new tab)
Grant
R44 · $1.5M · non-dilutive
Sep 8, 2025
XYLYX BIO, INC. · PI O'NEILL, JOHN DAVID · NHLBI · award ends Jun 30, 2027 · Translational development and clinical evaluation of a bioengineered human lung graft for clinical transplantation
NIH RePORTER · NIH RePORTER 11256353 (opens the source filing in a new tab)
Grant
R37 · $511k · non-dilutive
Sep 1, 2025
CASE WESTERN RESERVE UNIVERSITY · PI O'NEILL, WENDI QUINN · NCI · award ends Aug 31, 2030 · Biological factors driving clinical outcomes in HPV+ oropharyngeal cancer
NIH RePORTER · NIH RePORTER 11204140 (opens the source filing in a new tab)
Grant
R01 · $663k · non-dilutive
Aug 1, 2025
GEORGETOWN UNIVERSITY · PI SCHWARTZ, MARC D · NCI · award ends Jul 31, 2030 · Proactive Outreach and Streamlined Genetic Testing in Prostate Cancer Survivors
NIH RePORTER · NIH RePORTER 11230461 (opens the source filing in a new tab)
Grant
R01 · $547k · non-dilutive
May 1, 2025
GEORGETOWN UNIVERSITY · PI O'NEILL, SUZANNE C. · NCI · award ends Apr 30, 2030 · Bundled Multicancer Screening and Genetic Services Navigation to Improve Cancer Outcomes
NIH RePORTER · NIH RePORTER 11116110 (opens the source filing in a new tab)
Grant
R01 · $704k · non-dilutive
Apr 1, 2025
UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAIMAN, CHRISTOPHER ALAN · NCI · award ends Mar 31, 2030 · Family RESPOND: Defining the Genetic Basis of Prostate Cancer Risk in African American Families
NIH RePORTER · NIH RePORTER 11310151 (opens the source filing in a new tab)
Grant
R61 · $265k · non-dilutive
Sep 23, 2024
UNIVERSITY OF CALIFORNIA LOS ANGELES · PI O'NEILL, JOSEPH · NIAAA · award ends Aug 31, 2026 · Trigeminal Nerve Stimulation for Prenatal Alcohol Exposure
NIH RePORTER · NIH RePORTER 11196725 (opens the source filing in a new tab)
Grant
P20 · $130k · non-dilutive
Sep 5, 2024
WAYNE STATE UNIVERSITY · PI SCHWARTZ, ANN G. · NCI · award ends Aug 31, 2026 · Administrative Core
NIH RePORTER · NIH RePORTER 11184206 (opens the source filing in a new tab)
Grant
R44 · $968k · non-dilutive
Sep 1, 2024
XYLYX BIO, INC. · PI O'NEILL, JOHN DAVID · NIDDK · award ends Aug 31, 2027 · Liver fibrosis cell-based assay platform: integrating patient-derived fibrotic liver ECM with primary stellate cells, Kupffer cells, and hepatocytes to accelerate anti-fibrotic drug development
NIH RePORTER · NIH RePORTER 11249098 (opens the source filing in a new tab)
Trial
NA registered
Jul 31, 2024
Hereditary Cancer, Genetic Testing · RECRUITING · sponsor: Rutgers, The State University of New Jersey · Addressing Genomic Disparities in Cancer Survivors
ClinicalTrials.gov · NCT06073626 (opens the source filing in a new tab)
Grant
R44 · $966k · non-dilutive
Jun 6, 2024
XYLYX BIO, INC. · PI O'NEILL, JOHN DAVID · NCI · award ends May 31, 2027 · Multi-organ metastatic breast cancer cell-based assay platform that models organotropic metastases using patient organoids in human tissue-derived ECMs to accelerate anti-metastatic drug development
NIH RePORTER · NIH RePORTER 11109706 (opens the source filing in a new tab)
Trial
NA registered
Jun 3, 2024
Post-COVID Conditions, Obesity · RECRUITING · sponsor: VA Office of Research and Development · Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation
ClinicalTrials.gov · NCT05880108 (opens the source filing in a new tab)
Grant
P01 · $71k · non-dilutive
Feb 13, 2024
WAYNE STATE UNIVERSITY · PI BEEBE-DIMMER, JENNIFER L · NCI · award ends Jan 31, 2030 · Project 2
NIH RePORTER · NIH RePORTER 11287874 (opens the source filing in a new tab)
Grant
P01 · $227k · non-dilutive
Feb 13, 2024
WAYNE STATE UNIVERSITY · PI SCHWARTZ, ANN G. · NCI · award ends Jan 31, 2030 · Core 1
NIH RePORTER · NIH RePORTER 11287882 (opens the source filing in a new tab)
Grant
P01 · $52k · non-dilutive
Feb 13, 2024
WAYNE STATE UNIVERSITY · PI SCHWARTZ, ANN G. · NCI · award ends Jan 31, 2030 · Admin Core
NIH RePORTER · NIH RePORTER 11287879 (opens the source filing in a new tab)
Grant
P01 · $612k · non-dilutive
Feb 13, 2024
WAYNE STATE UNIVERSITY · PI SCHWARTZ, ANN G. · NCI · award ends Jan 31, 2030 · Genetic Variation in Cancer Risk and Outcomes in African Americans
NIH RePORTER · NIH RePORTER 11287871 (opens the source filing in a new tab)
Grant
R01 · $722k · non-dilutive
Feb 1, 2024
VANDERBILT UNIVERSITY MEDICAL CENTER · PI BACCHETTA, MATTHEW DOMINIC · NHLBI · award ends Jan 31, 2028 · The Road to Destination Therapy: Developing a Durable Ambulatory Mechanical Cardiopulmonary Support for Pulmonary Hypertension
NIH RePORTER · NIH RePORTER 11261531 (opens the source filing in a new tab)
Grant
R35 · $927k · non-dilutive
Sep 1, 2023
GEORGETOWN UNIVERSITY · PI MANDELBLATT, JEANNE · NCI · award ends Aug 31, 2030 · Investigations CONNECTing Cancer and Aging (I-CONNECT)
NIH RePORTER · NIH RePORTER 11172553 (opens the source filing in a new tab)
Grant
R01 · $780k · non-dilutive
Jun 15, 2023
UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CARROLL, JUDITH E · NIA · award ends Feb 29, 2028 · Patterns of biological, cognitive, and physical aging in cancer survivors and controls and the role of sleep health: Relevance for Alzheimer's Disease and Related Dementias
NIH RePORTER · NIH RePORTER 11306080 (opens the source filing in a new tab)
Grant
R01 · $652k · non-dilutive
May 5, 2023
COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LLANOS, ADANA A. M. · NIMHD · award ends Nov 30, 2027 · Assessing Cervical Cancer Healthcare Inequities in Diverse Populations: The ACHIEVE Study
NIH RePORTER · NIH RePORTER 11424416 (opens the source filing in a new tab)
Grant
R01 · $620k · non-dilutive
Mar 9, 2023
RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI KINNEY, ANITA Y. · NCI · award ends Jan 31, 2028 · Addressing Genomic Disparities in Cancer Survivors
NIH RePORTER · NIH RePORTER 11263647 (opens the source filing in a new tab)
Grant
I01 · non-dilutive
Oct 1, 2022
BALTIMORE VA MEDICAL CENTER · PI RYAN, ALICE S. · VA · award ends Sep 30, 2026 · Home-Based Exercise Tele-Rehabilitation in High-Risk Veterans: Impact of COVID-19 Exposure and Socioeconomic Factors
NIH RePORTER · NIH RePORTER 11305968 (opens the source filing in a new tab)
Grant
R33 · $759k · non-dilutive
Sep 30, 2022
GEORGETOWN UNIVERSITY · PI MANDELBLATT, JEANNE · NIA · award ends Apr 30, 2027 · I-REACH (Infrastructure for REsearch on Cancer and Aging)
NIH RePORTER · NIH RePORTER 11169001 (opens the source filing in a new tab)
Grant
R33 · $774k · non-dilutive
Sep 30, 2022
GEORGETOWN UNIVERSITY · PI MANDELBLATT, JEANNE · NIA · award ends Apr 30, 2027 · I-REACH (Infrastructure for REsearch on Cancer and Aging)
NIH RePORTER · NIH RePORTER 11377972 (opens the source filing in a new tab)
Grant
R01 · $372k · non-dilutive
Sep 20, 2022
COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LLANOS, ADANA A. M. · NCI · award ends Aug 31, 2026 · Impact of Allostatic Load and Neighborhood Contextual Factors on Breast Cancer in the Women's Health Initiative
NIH RePORTER · NIH RePORTER 11373145 (opens the source filing in a new tab)
Grant
IK6 · non-dilutive
Jul 1, 2022
BALTIMORE VA MEDICAL CENTER · PI RYAN, ALICE S. · VA · award ends Jun 30, 2029 · RR&D Research Career Scientist Award Application
NIH RePORTER · NIH RePORTER 11092767 (opens the source filing in a new tab)
Grant
R01 · $662k · non-dilutive
Apr 1, 2022
RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI KINNEY, ANITA Y. · NHLBI · award ends Mar 31, 2027 · TELEhealth Shared decision-making COaching for lung cancer screening in Primary care (TELESCOPE)
NIH RePORTER · NIH RePORTER 11311265 (opens the source filing in a new tab)
Grant
T32 · $258k · non-dilutive
Aug 1, 2021
GEORGETOWN UNIVERSITY · PI O'NEILL, SUZANNE C. · NCI · award ends Jul 31, 2026 · Training Program in Cancer Population Science (CaPS)
NIH RePORTER · NIH RePORTER 11160625 (opens the source filing in a new tab)
Grant
K00 · $93k · non-dilutive
Aug 3, 2020
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI O'NEILL, KATHLEEN · NCI · award ends Jul 31, 2026 · Lysosomal metabolism as a targetable driver of pancreatic cancer
NIH RePORTER · NIH RePORTER 11139572 (opens the source filing in a new tab)
Trial
NA registered
May 1, 2020
BRCA1 Mutation, BRCA2 Mutation · ENROLLING_BY_INVITATION · sponsor: Georgetown University · Genetic Education in BRCA Families
ClinicalTrials.gov · NCT03544983 (opens the source filing in a new tab)
Grant
UG1 · $471k · non-dilutive
Aug 7, 2019
GEORGETOWN UNIVERSITY · PI ADAMS-CAMPBELL, LUCILE L. · NCI · award ends Jul 31, 2026 · National Capital Area (NCA) NCI Community Oncology Research Program (NCORP)
NIH RePORTER · NIH RePORTER 11336619 (opens the source filing in a new tab)
Grant
U01 · $103k · non-dilutive
Feb 27, 2017
WAYNE STATE UNIVERSITY · PI SCHWARTZ, ANN G. · NCI · award ends Feb 28, 2027 · Detroit Research on Cancer Survivors (Detroit ROCS)
NIH RePORTER · NIH RePORTER 11396745 (opens the source filing in a new tab)
Grant
U01 · $1.1M · non-dilutive
Feb 27, 2017
WAYNE STATE UNIVERSITY · PI SCHWARTZ, ANN G. · NCI · award ends Feb 28, 2027 · Detroit Research on Cancer Survivors (Detroit ROCS)
NIH RePORTER · NIH RePORTER 11287860 (opens the source filing in a new tab)
Trial
NA registered
Feb 15, 2017
Breast Density, Breast Cancer Female · COMPLETED · sponsor: Georgetown University · ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2
ClinicalTrials.gov · NCT03029286 (opens the source filing in a new tab)
Grant
P30 · $212k · non-dilutive
Apr 15, 2011
UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI O'NEILL, MARIE SYLVIA · NIEHS · award ends Mar 31, 2027 · Integrated Health Sciences Core
NIH RePORTER · NIH RePORTER 11060060 (opens the source filing in a new tab)
Grant
P30 · $202k · non-dilutive
Apr 15, 2011
UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI O'NEILL, MARIE SYLVIA · NIEHS · award ends Mar 31, 2027 · Integrated Health Sciences Core
NIH RePORTER · NIH RePORTER 11362350 (opens the source filing in a new tab)
Grant
P30 · $207k · non-dilutive
Sep 15, 2006
UNIVERSITY OF MARYLAND BALTIMORE · PI RYAN, ALICE S. · NIA · award ends Jun 30, 2027 · Applied Physiology and Mechanisms
NIH RePORTER · NIH RePORTER 11134599 (opens the source filing in a new tab)
Grant
P30 · $1.2M · non-dilutive
Sep 15, 2006
UNIVERSITY OF MARYLAND BALTIMORE · PI RYAN, ALICE S. · NIA · award ends Jun 30, 2027 · University of Maryland Claude D. Pepper Older Americans Independence Center (OAIC)
NIH RePORTER · NIH RePORTER 11134565 (opens the source filing in a new tab)
Grant
P30 · $219k · non-dilutive
Sep 15, 2006
UNIVERSITY OF MARYLAND BALTIMORE · PI MAGAZINER, JAY · NIA · award ends Jun 30, 2027 · Leadership Administration Core
NIH RePORTER · NIH RePORTER 11134593 (opens the source filing in a new tab)
Grant
P30 · $695k · non-dilutive
Sep 30, 1997
UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TAYLOR, ROBERT JOSEPH · NIA · award ends Jun 30, 2028 · Michigan Center for Urban African American Aging Research
NIH RePORTER · NIH RePORTER 11134544 (opens the source filing in a new tab)
Grant
P30 · $372k · non-dilutive
Aug 15, 1997
GEORGETOWN UNIVERSITY · PI DASH, CHIRANJEEV · NCI · award ends Apr 30, 2029 · Community Outreach and Engagement
NIH RePORTER · NIH RePORTER 11323922 (opens the source filing in a new tab)
Grant
P30 · $108k · non-dilutive
Aug 8, 1997
WAYNE STATE UNIVERSITY · PI BEEBE-DIMMER, JENNIFER L · NCI · award ends Nov 30, 2026 · Epidemiology Research Core (ERC)
NIH RePORTER · NIH RePORTER 11514604 (opens the source filing in a new tab)
Grant
P30 · $41k · non-dilutive
Aug 8, 1997
WAYNE STATE UNIVERSITY · PI BEEBE-DIMMER, JENNIFER L · NCI · award ends Nov 30, 2026 · Population Studies and Disparities Research
NIH RePORTER · NIH RePORTER 11478116 (opens the source filing in a new tab)
Grant
P30 · $269k · non-dilutive
Mar 1, 1997
RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI KINNEY, ANITA Y. · NCI · award ends Feb 28, 2029 · Community Outreach and Engagement
NIH RePORTER · NIH RePORTER 11317120 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 1.00name similarity 100% · semantic similarity 87% · shared principal investigator / founder · same city · same therapeutic area
Shared principal investigator or founder links the grant record at 0.99name similarity 100% · semantic similarity 81% · shared principal investigator / founder · same city
Shared principal investigator or founder links the grant record at 0.75principal investigator O'NEILL, SUZANNE C. is named on this company's filings
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
new_entity links the grant record at 0.09same therapeutic area

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Phase II trial registered: Duloxetine and aeRobic Exercise to Improve Function in VEterans With Knee Osteoarthritis (DRIVE)
4w agoTrial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation
6w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation
6w agoTrial recruitingSource (opens the source filing in a new tab)
NIH P30 · $0.4M · Community Outreach and Engagement
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH P01 · $0.1M · Project 2
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH P01 · $0.2M · Core 1
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH P01 · $0.1M · Admin Core
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH P01 · $0.6M · Genetic Variation in Cancer Risk and Outcomes in African Americans
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Family RESPOND: Defining the Genetic Basis of Prostate Cancer Risk in African American Families
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH P30 · $0.1M · Epidemiology Research Core (ERC)
3mo agoGrant renewalSource (opens the source filing in a new tab)
NIH P30 · $0.0M · Population Studies and Disparities Research
3mo agoGrant renewalSource (opens the source filing in a new tab)
NIH P30 · $0.2M · Integrated Health Sciences Core
3mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R33 · $0.8M · I-REACH (Infrastructure for REsearch on Cancer and Aging)
3mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · TELEhealth Shared decision-making COaching for lung cancer screening in Primary care (TELESCOPE)
3mo agoGrant renewalSource (opens the source filing in a new tab)
NIH P30 · $0.3M · Community Outreach and Engagement
4mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.8M · Patterns of biological, cognitive, and physical aging in cancer survivors and controls and the role of sleep health: Relevance for Alzheimer's Disease and Related Dementias
4mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · The Road to Destination Therapy: Developing a Durable Ambulatory Mechanical Cardiopulmonary Support for Pulmonary Hypertension
4mo agoGrant renewalSource (opens the source filing in a new tab)
NIH U01 · $1.1M · Detroit Research on Cancer Survivors (Detroit ROCS)
5mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Assessing Cervical Cancer Healthcare Inequities in Diverse Populations: The ACHIEVE Study
5mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.6M · Addressing Genomic Disparities in Cancer Survivors
6mo agoGrant renewalSource (opens the source filing in a new tab)
Study registered, no phase assigned: Genetic Education in BRCA Families
8mo agoTrial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: Addressing Genomic Disparities in Cancer Survivors
8mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Addressing Genomic Disparities in Cancer Survivors
8mo agoTrial recruitingSource (opens the source filing in a new tab)
NIH P20 · $0.1M · Administrative Core
10mo agoGrant renewalSource (opens the source filing in a new tab)
NIH I01 · Home-Based Exercise Tele-Rehabilitation in High-Risk Veterans: Impact of COVID-19 Exposure and Socioeconomic Factors
10mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R44 · $1.0M · Liver fibrosis cell-based assay platform: integrating patient-derived fibrotic liver ECM with primary stellate cells, Kupffer cells, and hepatocytes to accelerate anti-fibrotic drug development
10mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R44 · $1.5M · Translational development and clinical evaluation of a bioengineered human lung graft for clinical transplantation
10mo agoNew grantSource (opens the source filing in a new tab)
NIH U01 · $0.1M · Detroit Research on Cancer Survivors (Detroit ROCS)
10mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.4M · Impact of Allostatic Load and Neighborhood Contextual Factors on Breast Cancer in the Women's Health Initiative
10mo agoGrant renewalSource (opens the source filing in a new tab)
NIH P30 · $0.7M · Michigan Center for Urban African American Aging Research
10mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R37 · $0.5M · Biological factors driving clinical outcomes in HPV+ oropharyngeal cancer
11mo agoNew grantSource (opens the source filing in a new tab)
NIH R61 · $0.3M · Trigeminal Nerve Stimulation for Prenatal Alcohol Exposure
11mo agoGrant renewalSource (opens the source filing in a new tab)
NIH UG1 · $0.5M · National Capital Area (NCA) NCI Community Oncology Research Program (NCORP)
11mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R35 · $0.9M · Investigations CONNECTing Cancer and Aging (I-CONNECT)
11mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Proactive Outreach and Streamlined Genetic Testing in Prostate Cancer Survivors
11mo agoNew grantSource (opens the source filing in a new tab)
NIH P30 · $0.2M · Applied Physiology and Mechanisms
11mo agoGrant renewalSource (opens the source filing in a new tab)
NIH P30 · $1.2M · University of Maryland Claude D. Pepper Older Americans Independence Center (OAIC)
11mo agoGrant renewalSource (opens the source filing in a new tab)
NIH P30 · $0.2M · Leadership Administration Core
11mo agoGrant renewalSource (opens the source filing in a new tab)
NIH IK6 · RR&D Research Career Scientist Award Application
11mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R33 · $0.8M · I-REACH (Infrastructure for REsearch on Cancer and Aging)
12mo agoGrant renewalSource (opens the source filing in a new tab)
NIH T32 · $0.3M · Training Program in Cancer Population Science (CaPS)
Jul 2025Grant renewalSource (opens the source filing in a new tab)
NIH K00 · $0.1M · Lysosomal metabolism as a targetable driver of pancreatic cancer
Jul 2025Grant renewalSource (opens the source filing in a new tab)
NIH P30 · $0.2M · Integrated Health Sciences Core
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R44 · $1.0M · Multi-organ metastatic breast cancer cell-based assay platform that models organotropic metastases using patient organoids in human tissue-derived ECMs to accelerate anti-metastatic drug development
Jun 2025Grant renewalSource (opens the source filing in a new tab)
Study registered, no phase assigned: ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2
Apr 2025Trial registeredSource (opens the source filing in a new tab)
Trial completed: ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2
Apr 2025Trial completedSource (opens the source filing in a new tab)
NIH R01 · $0.5M · Bundled Multicancer Screening and Genetic Services Navigation to Improve Cancer Outcomes
Apr 2025New grantSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

PHASE2 registered

R44 · $1.5M · non-dilutive

R37 · $511k · non-dilutive

R01 · $663k · non-dilutive

R01 · $547k · non-dilutive

R01 · $704k · non-dilutive

R61 · $265k · non-dilutive

P20 · $130k · non-dilutive

R44 · $968k · non-dilutive

NA registered

R44 · $966k · non-dilutive

NA registered

P01 · $71k · non-dilutive

P01 · $227k · non-dilutive

P01 · $52k · non-dilutive

P01 · $612k · non-dilutive

R01 · $722k · non-dilutive

R35 · $927k · non-dilutive

R01 · $780k · non-dilutive

R01 · $652k · non-dilutive

R01 · $620k · non-dilutive

I01 · non-dilutive

R33 · $759k · non-dilutive

R33 · $774k · non-dilutive

R01 · $372k · non-dilutive

IK6 · non-dilutive

R01 · $662k · non-dilutive

T32 · $258k · non-dilutive

K00 · $93k · non-dilutive

NA registered

UG1 · $471k · non-dilutive

U01 · $103k · non-dilutive

U01 · $1.1M · non-dilutive

NA registered

P30 · $212k · non-dilutive

P30 · $202k · non-dilutive

P30 · $207k · non-dilutive

P30 · $1.2M · non-dilutive

P30 · $219k · non-dilutive

P30 · $695k · non-dilutive

P30 · $372k · non-dilutive

P30 · $108k · non-dilutive

P30 · $41k · non-dilutive

P30 · $269k · non-dilutive